[Question] how do you actually verify telehealth
Genuine question, and the title is the question: how do you actually verify telehealth.
The shortage list is the legal hinge: the permissions that allow certain compounding to happen at scale are tied to a drug’s shortage status, which changes.
Compounded preparations are not approved products and carry no bioequivalence claim. That is a statement about regulatory category, not about quality.
A 503A pharmacy compounds for an identified patient against a prescription. A 503B outsourcing facility registers with the regulator, may produce without patient-specific prescriptions, and is subject to current good manufacturing practice requirements. The two are governed differently and the difference is not cosmetic.
Would rather be corrected in public than confident in private.
best — the order this archive was captured in
Salt form matters for mass: a preparation specified as one salt and dosed as the free base gives you a different amount of peptide for the same number on the label.
the pharmacy and the prescriber are two separate questions
Correction: patient-specific refers to the prescription, not to a bespoke formulation. Common misreading and it changes the argument.
Correcting my own comment: the shortage status changed in the interim, so the arrangement I described no longer applies.
Correcting my own comment: the shortage status changed in the interim, so the arrangement I described no longer applies.
Adding one thing — ask for the facility name. Most will give it, and the ones that will not have answered you.
Small fix — 503B facilities register with the regulator; 503A pharmacies are licensed by the state board. Different mechanisms.
Right, and the concentration genuinely can differ from the branded product, which breaks people’s arithmetic.
That figure is the starting material purity, not the finished preparation potency. Two different tests.
Careful. Naming a clinic without describing what actually happened turns this into a different kind of thread.
Potency and sterility testing on the finished preparation are separate from any certificate covering the starting material. Ask which you are being shown.
a 503B has to register and report, so there is a paper trail to ask for
Potency and sterility testing on the finished preparation are separate from any certificate covering the starting material.
Disagreeing with this bit: registration is not equivalence, and the two get run together constantly.
the label on a compounded vial is a legal document, read it
the label on a compounded vial is a legal document, read it
hydration_hank is right about the concentration trap. It breaks arithmetic that has been reliable for months.
That is not what patient-specific means. It refers to the prescription, not to a customisation of the formula.
On concentration, which is where I see people actually get hurt.
A compounded vial can be filled at a different concentration from the branded product you were previously using. If you carry over your old arithmetic — same number of units, different mg/mL — you draw a different amount and may not notice for weeks.
Read the label every time you switch. Redo the arithmetic on paper. Write the concentration on the vial. It is the same habit c/reconstitution keeps preaching and this is the case where it actually bites.
Yes. The shortage list is the legal hinge for the whole arrangement and its status is public.
Same view. If the intake asked you nothing, the intake was a formality and you should factor that in.
What did the intake actually ask you?
Yes — asking which facility, by name, is the single most useful question and most clinics will answer it.
potency testing on the finished preparation is the thing to ask for
ask which facility, then ask for their testing
- 1Salt form matters for mass: a preparation specified as one salt and dosed as…8 comments in this branch · started by u/rafael_ostergaard
- 2Careful. Naming a clinic without describing what actually happened turns…6 comments in this branch · started by u/ayesha_radich